<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: Central <z:hpo ids='HP_0001513'>obesity</z:hpo> is a risk factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and esophageal adeno-<z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies have suggested that adipocytokines are the possible link between <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> and Barrett's <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>To determine the adiponectin, resistin and leptin concentration as well as the central <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> parameters in BE patients with and without <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (IM) in comparison to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>METHODOLOGY: Total of 77 patients (30 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, 26 BE with IM and 21 BE without IM) and 30 healthy controls were investigated for the central <z:hpo ids='HP_0001513'>obesity</z:hpo> parameters </plain></SENT>
<SENT sid="4" pm="."><plain>Serum levels of adipocytokines were measured with ELISA </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The serum concentration of adiponectin was significantly lower in BE compared to those in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and to controls (p&lt;0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Levels of leptin was slightly higher in BE than in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and controls (NS) </plain></SENT>
<SENT sid="7" pm="."><plain>Level of resistin was significantly higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> compared to both control and BE patients (p&lt;0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>Waist circumference, WHR and WTR were significantly higher in BE patients compared to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> (p&lt;0.001) and to control group (p&lt;0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Features of central <z:hpo ids='HP_0001513'>obesity</z:hpo> rather than BMI are associated with BE development </plain></SENT>
<SENT sid="10" pm="."><plain>Adipokines may be important at the early step of BE development, before the IM occurrence </plain></SENT>
</text></document>